News for 'India's Food and Drug Administration'

FSSAI-approved lab finds Maggi noodles safe

FSSAI-approved lab finds Maggi noodles safe

Rediff.com4 Aug 2015

Many countries found Maggi noodles to be safe for consumption.

Approval delays to hurt Indian pharma cos' US sales

Approval delays to hurt Indian pharma cos' US sales

Rediff.com13 Nov 2014

Some Indian generic drugmakers are, however, uncertain about the pace of approvals in the near future.

Regulator might inspect Wockhardt units

Regulator might inspect Wockhardt units

Rediff.com12 Jun 2013

Last month, the US Food and Drugs Administration had placed Wockhardt's facilities in Waluj near Aurangabad on import alert, barring supply of various products from these facilities to the US.

FDA raises concern over US unit: Wockhardt

FDA raises concern over US unit: Wockhardt

Rediff.com28 May 2014

Wockhardt MD Murtaza Khorakiwala said his firm had responded to the FDA's observations but declined to give details.

States fail to find lead in Maggi noodles

States fail to find lead in Maggi noodles

Rediff.com19 Jun 2015

Test reports from UP food regulator started the controversy.

US students who took Covaxin, Sputnik asked to get re-vaccinated

US students who took Covaxin, Sputnik asked to get re-vaccinated

Rediff.com4 Jun 2021

These vaccines have not yet been approved by the World Health Organization

Now, US FDA gets a call from Indian pharma companies

Now, US FDA gets a call from Indian pharma companies

Rediff.com27 Oct 2013

The Indian Pharmaceutical Alliance has approached regulator for a dialogue to understand the concern raised by it

Nestl comes up with 'miss-you Maggi' ads

Nestl comes up with 'miss-you Maggi' ads

Rediff.com26 Aug 2015

The under-one-minute films are titled 'Menu Cards, Mom and Neighbours'.

'Everybody's going to get infected'

'Everybody's going to get infected'

Rediff.com27 Dec 2021

'In the likelihood that Omicron is circulating, you have a much greater chance of getting infected now, than you did during the Age of Delta.'

Indian pharma cos shifting R&D to SE Asian countries

Indian pharma cos shifting R&D to SE Asian countries

Rediff.com4 Jul 2013

South-east Asian countries are emerging as preferable destination for India's pharma companies to expand their business as they share similar patient population and disease profile and moreover, have a conducive environment for their operations like easy market approach without any regulatory uncertainty, the survey of Indian pharma firms highlighted.

Sun-Ranbaxy merger may spill over to 2015

Sun-Ranbaxy merger may spill over to 2015

Rediff.com15 Nov 2014

The Competition Commission of India and the US Federal Trade Commission are yet to give their nod to the biggest pharma merger and acquisition deal this year in the Asia-Pacific region.

Another big blow for Ranbaxy

Another big blow for Ranbaxy

Rediff.com22 Aug 2014

Slapped with Rs 242-crore fine by US authorities for rule violations at Toansa unit, say sources; 2nd such hefty rap in the recent past from US regulators for bending rules.

7 Indian pharma players race to develop COVID-19 vaccine

7 Indian pharma players race to develop COVID-19 vaccine

Rediff.com19 Jul 2020

Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.

Wockhardt: Recovery not in sight yet

Wockhardt: Recovery not in sight yet

Rediff.com5 Nov 2014

The news that exports to the US will not restart before next year as well as the September quarter performance are sentiment dampeners.

Experts welcome WHO's decision to resume HCQ clinical trial

Experts welcome WHO's decision to resume HCQ clinical trial

Rediff.com4 Jun 2020

The global heath body had earlier suspended the hydroxychloroquine arm of the clinical trials of experimental COVID-19 drugs over safety concerns.

Piramal Enterprises to stop early-stage research

Piramal Enterprises to stop early-stage research

Rediff.com28 Aug 2014

To focus on molecules at advanced stage of development; move to impact 200 scientists.

India, Thailand to forge close ties in defence, cyber security, economy

India, Thailand to forge close ties in defence, cyber security, economy

Rediff.com17 Jun 2016

Thailand expressed interest in the Indian defence industry and its experience and expertise in the field of defence R&D and production. Modi welcomed Thai investments in India in the potential areas under the 'Make in India' initiative, especially in the manufacturing sector, infrastructure development, tourism and hospitality facilities.

'Centre can't abdicate its responsibility'

'Centre can't abdicate its responsibility'

Rediff.com24 Apr 2023

'The Centre and state need to take a unified approach and take concerted action before this matter assumes menacing proportions because unemployment, the drug trade and the levels of frustration among the youth make them vulnerable to any maverick who promises something better.'

Profit might be hit in FY16: Sun Pharma

Profit might be hit in FY16: Sun Pharma

Rediff.com21 Jul 2015

4 Ranbaxy facilities in India have been barred from exporting to US.

Ranbaxy brand may fade away as Sun takes charge

Ranbaxy brand may fade away as Sun takes charge

Rediff.com10 Dec 2014

The joint entity will have a market share of nine per cent in India. Analysts tracking the company said one of the key outcomes of the merger would be to create a single brand entity of Sun and the Ranbaxy brand would eventually dissolve.

Sensex retreats from 6-week high, slides 253 points

Sensex retreats from 6-week high, slides 253 points

Rediff.com15 Mar 2016

Of the 30-share Sensex pack, 22 ended with losses while NTPC ended flat at Rs 127.30.

Experts unsure of Maha move to challenge Maggi in Supreme Court

Experts unsure of Maha move to challenge Maggi in Supreme Court

Rediff.com16 Nov 2015

Maggi re-entered the market on November 9.

Maggi in a soup: Brands that fought back controversies and regained trust

Maggi in a soup: Brands that fought back controversies and regained trust

Rediff.com6 Jun 2015

Instant noodle from Nestle is not the first food brand in India to have faced a tough time though

Sensex ends flat after hitting life-time high of 28,283

Sensex ends flat after hitting life-time high of 28,283

Rediff.com18 Nov 2014

Roadshows will be held in Singapore, Hong Kong, London, New York and Boston, NTPC gained close to 1%.

Khurshid raises concern over Devyani issue with Kerry

Khurshid raises concern over Devyani issue with Kerry

Rediff.com23 Jan 2014

Upset over the Devyani Khobragade episode, India on Wednesday raised with the United States its concerns over "trafficking" visas issued to family members of Sangita Richard, the absconding maid of the Indian diplomat whose arrest had triggered a row between the two countries.

Wockhardt medicines banned in Europe

Wockhardt medicines banned in Europe

Rediff.com11 Jul 2013

Its Waluj manufacturing facility in Maharashtra failed to meet the good manufacturing norms prescribed by the UK drug regulator.

Maggi to lose $200 mn in brand value

Maggi to lose $200 mn in brand value

Rediff.com18 Jun 2015

Asset valuation consultancy sees brand value slip to $2.2 billion.

The A-W Of Desi Guests At the White House Dinner

The A-W Of Desi Guests At the White House Dinner

Rediff.com24 Jun 2023

The dinner Jill Biden and her husband US President Joe Biden hosted for Indian prime minister Narendra Modi, June 22, at the White House brought together, Indians and Americans from so many firmaments.

'No one is saying the vaccine is unsafe'

'No one is saying the vaccine is unsafe'

Rediff.com8 Jan 2021

'Nobody is attacking the company or the vaccine.' 'The concerns are about the process and the lack of transparency.'

Ranbaxy hires BCG, Mercer for internal strategic project

Ranbaxy hires BCG, Mercer for internal strategic project

Rediff.com1 Jun 2013

Consultants are working with various teams on manufacturing, R&D, etc, to assess per-month productivity of each department.

Oil from cannabis seed is the new elixir

Oil from cannabis seed is the new elixir

Rediff.com25 Jan 2020

CBD oil, found in marijuana, is gaining popularity for its pain-relieving properties. It's now legally available in India

Pharma sector in alarm over govt's cure

Pharma sector in alarm over govt's cure

Rediff.com28 Oct 2017

The government plans to rationalise trade margins for many other medical devices, besides stents and knee implants.

Sun-Ranbaxy deal signals Indian pharma cos are smart targets

Sun-Ranbaxy deal signals Indian pharma cos are smart targets

Rediff.com8 Apr 2014

The Ranbaxy experience has made multinational corporations more cautious about Indian acquisitions in general

Travel restrictions imposed after 1st coronavirus death in US

Travel restrictions imposed after 1st coronavirus death in US

Rediff.com1 Mar 2020

Vice President Mike Pence said Trump had authorised a ban on entry of foreign nationals who travelled to Iran in the last 14 days. The United States also advised its citizens not to travel to parts of South Korea and Italy, from where reports of coronavirus have appeared.

Booster dose of anti-Covid vax not needed at this stage: Experts

Booster dose of anti-Covid vax not needed at this stage: Experts

Rediff.com18 Sep 2021

As the global debate on booster shots gathers momentum, several scientists in New Delhi said the priority must be to ensure that more people are inoculated with at least their first jab.

ICMR to conduct nationwide sero surveys on Covid spread

ICMR to conduct nationwide sero surveys on Covid spread

Rediff.com12 Jun 2021

The Indian Council of Medical Research will start national-level sero surveys to assess the spread of Covid-19 and all states/Union territories should also be encouraged to conduct them so that information from all geographies can be collected, the Union health ministry said on Friday.

Meet the man behind the Sun Pharma-Ranbaxy deal

Meet the man behind the Sun Pharma-Ranbaxy deal

Rediff.com8 Apr 2014

Sun Pharma's offer was tempting because Ranbaxy was too busy fighting fires in the US to concentrate on operations.

Is it the end of brand 'Maggi' or will Nestle strike back?

Is it the end of brand 'Maggi' or will Nestle strike back?

Rediff.com2 Jun 2015

Experts question Nestle's silence over Maggi controversy.

India can deliver COVID-19 vaccine swiftly and efficiently

India can deliver COVID-19 vaccine swiftly and efficiently

Rediff.com4 Jan 2021

'Rolling out the vaccine is not a major challenge in India.'

'Shift FSSAI from health to consumer affairs ministry'

'Shift FSSAI from health to consumer affairs ministry'

Rediff.com8 Jul 2015

The matter is now expected to be raised with the PMO.